Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 1
1996 2
1997 1
2005 1
2006 4
2007 1
2008 4
2009 2
2010 7
2011 6
2012 3
2013 2
2018 4
2019 3
2020 3
2021 3
2022 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

44 results

Results by year

Filters applied: . Clear all
Page 1
Targeted biopsy: benefits and limitations.
Purnell SD, Bloom JB, Valera V, Wood BJ, Turkbey B, Pinto PA. Purnell SD, et al. Among authors: valera v. Curr Opin Urol. 2018 Mar;28(2):219-226. doi: 10.1097/MOU.0000000000000481. Curr Opin Urol. 2018. PMID: 29334506 Review.
Risk of adverse pathology at prostatectomy in the era of MRI and targeted biopsies; rethinking active surveillance for intermediate risk prostate cancer patients.
Bloom JB, Daneshvar MA, Lebastchi AH, Ahdoot M, Gold SA, Hale G, Mehralivand S, Sanford T, Valera V, Wood BJ, Choyke PL, Merino MJ, Turkbey B, Parnes HL, Pinto PA. Bloom JB, et al. Among authors: valera v. Urol Oncol. 2021 Oct;39(10):729.e1-729.e6. doi: 10.1016/j.urolonc.2021.02.018. Epub 2021 Mar 16. Urol Oncol. 2021. PMID: 33736975 Review.
Comprehensive microRNA Profiling of Prostate Cancer.
Walter BA, Valera VA, Pinto PA, Merino MJ. Walter BA, et al. Among authors: valera va. J Cancer. 2013 May 9;4(5):350-7. doi: 10.7150/jca.6394. Print 2013. J Cancer. 2013. PMID: 23781281 Free PMC article.
Cabozantinib plus Nivolumab Phase I Expansion Study in Patients with Metastatic Urothelial Carcinoma Refractory to Immune Checkpoint Inhibitor Therapy.
Girardi DM, Niglio SA, Mortazavi A, Nadal R, Lara P, Pal SK, Saraiya B, Cordes L, Ley L, Ortiz OS, Cadena J, Diaz C, Bagheri H, Redd B, Steinberg SM, Costello R, Chan KS, Lee MJ, Lee S, Yu Y, Gurram S, Chalfin HJ, Valera V, Figg WD, Merino M, Toubaji A, Streicher H, Wright JJ, Sharon E, Parnes HL, Ning YM, Bottaro DP, Cao L, Trepel JB, Apolo AB. Girardi DM, et al. Among authors: valera v. Clin Cancer Res. 2022 Apr 1;28(7):1353-1362. doi: 10.1158/1078-0432.CCR-21-3726. Clin Cancer Res. 2022. PMID: 35031545 Free PMC article.
44 results